Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hodgkin Disease
- Multiple Myeloma
- Non Hodgkin Lymphoma
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: This is a multicenter, two-arm randomized controlled trial. Randomization will be stratified by study site, primary cancer diagnosis (MM versus HD versus NHL) and transplantation setting (inpatient versus outpatient) to ensure these characteristics are comparably distributed between the two study arms.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04459416
- Collaborators
- Patient-Centered Outcomes Research Institute
- Hackensack Meridian Health
- Investigators
- Principal Investigator: Gary Deng, MD, PhD Memorial Sloan Kettering Cancer Center
Get Well Soon